scispace - formally typeset
S

Samo Jeverica

Researcher at University of Ljubljana

Publications -  37
Citations -  800

Samo Jeverica is an academic researcher from University of Ljubljana. The author has contributed to research in topics: Helicobacter pylori & Clarithromycin. The author has an hindex of 14, co-authored 34 publications receiving 614 citations.

Papers
More filters
Journal ArticleDOI

Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey.

TL;DR: This work provides the first use of joint analysis of WGS and epidemiological data in an international programme for regional surveillance of sexually transmitted infections and provides a framework for genomic surveillance of gonococci through standardised sampling, use of W GS, and a shared information architecture for interpretation and dissemination.
Journal ArticleDOI

Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.

TL;DR: The second case in Europe of verified treatment failure of pharyngeal gonorrhoea, caused by an internationally occurring multidrug-resistant gonococcal clone, with recommended first-line ceftriaxone 250 mg in Slovenia is described.
Journal ArticleDOI

Evaluation of the routine antimicrobial susceptibility testing results of clinically significant anaerobic bacteria in a Slovenian tertiary-care hospital in 2015.

TL;DR: High overall resistance to clindamycin was detected in this study and was highest among the genera Prevotella, Bacteroide, Parabacteroides, GPACs and Clostridium and the species identification was performed by MALDI-TOF mass spectrometry.
Journal ArticleDOI

Nano-engineering the Antimicrobial Spectrum of Lantibiotics: Activity of Nisin against Gram Negative Bacteria

TL;DR: For the first time, it is shown that this type of structure enables interactions capable of disintegrating the wall of Gram negative bacteria, and opens up new horizons for the use of lantibiotics in designing post-antibiotic drugs.